1"use strict";(self.webpackChunkgilead_hiv=self.webpackChunkgilead_hiv||[]).push([[435],{8417:function(e,t,a){a.d(t,{A:function(){return i}});var n=a(7387),r=a(6540),o=a(263);var i=function(e){function t(t){return e.call(this)||this}return(0,n.A)(t,e),t.prototype.render=function(){return r.createElement(r.Fragment,null,r.createElement(o.A,{className:"cont-video",centered:!0,show:this.props.show,onHide:this.props.handleClose},r.createElement("img",{className:"close-button",onClick:this.props.handleClose,src:"data:image/png;base64,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"}),r.createElement(o.A.Body,null,r.createElement("video",{className:"video-player",poster:this.props.thumbnail,autoPlay:!0,controls:!0,controlsList:"nodownload",disablePictureInPicture:!0,"data-video-track-label":this.props.videoTrackLabel,id:"1111"},r.createElement("source",{src:this.props.url,type:"video/mp4"}),this.props.closedCaptions&&r.createElement("track",{label:"English",kind:"subtitles",srcLang:"en",src:this.props.closedCaptions})))))},t}(r.Component)},1591:function(e,t,a){a.r(t),a.d(t,{default:function(){return I}});var n=a(7387),r=a(6540),o=a(3270),i=a(8417),s=a.p+"static/helping-break-down-barriers-4c5acb1f6cd4dae7b295274b3a4eca14.jpg",l=a.p+"static/helping-break-down-barriers-mobile-73df71a5495c3542ec30722057d861c8.jpg",c=a.p+"static/Stop-the-virus-logo-281c9807d23b4db467dba3e6c0ed99b9.png",m=a.p+"static/healthysexual-logo-936fbd6f61d18944284db4f1ca6efb31.png",d=a.p+"static/Support-and-resources-together-26e739c5aab174a2574bd3d669662068.jpg",p=a.p+"static/Support-and-resources-together-mobile-ca9fceefc6bbbd38120df3a19e1b12b7.jpg",h=a(3048),u=a(4479),g=a(1105),E=a(3904),b=a(9498),f=a(4692),v=a.n(f);var w=function(e){function t(){var t;return(t=e.call(this)||this).handleClose=e=>{t.setState({show:!1})},t.handleShow=e=>{t.setState({show:!0})},t.componentDidMount=()=>{v()("[data-jump-link").on("click",e=>{let t=v()(e.currentTarget).attr("data-jump-link"),a=v()('[data-jump-destination="'+t+'"]'),n=v()(a).offset().top,r=v()(window).width()<=574?100:30;"undefined"!=typeof window&&window.scrollTo({top:n-r,behavior:"smooth"})})},t.state={show:!1},t}return(0,n.A)(t,e),t.prototype.render=function(){return r.createElement("div",{className:`\n ${this.props.show?"d-block":"d-none"}\n about\n `},r.createElement(h.A,{fluid:!0,className:"hero about",role:"img","aria-label":"Together image with 5 people together, basking in the sun, some with eyes closed, full color"}),r.createElement(h.A,{className:"px-0"},r.createElement(u.A,null,r.createElement(g.A,{xs:10,className:"mx-auto"},r.createElement("div",{className:"hero-callout all-together"},r.createElement("h1",{className:"title"},"We Are All In This Together"))))),r.createElement(h.A,{className:"px-0"},r.createElement(u.A,null,r.createElement(g.A,{xs:10,className:"mx-auto pt-0"},r.createElement(h.A,{fluid:!0},r.createElement(u.A,null,r.createElement(g.A,{xs:12,className:"p-0 mb-standard"},r.createElement("p",null,"When it comes to helping"," ",r.createElement("a",{href:"/landscape/ehe"},"end the HIV epidemic"),", weâre all in this together. Not just for one, but for the many. We recognize our role within the HIV community and that by working together with community organizations, allied healthcare professionals, and advocates every day, we can help improve the lives of everyone living with HIV, and for those affected by HIV. We're dedicated to standing with the HIV community, advancing research and development, and supporting organizations making meaningful change to help all those impacted by HIV live longer, healthier lives."," "),r.createElement("figure",{className:"pt-3 mt-3"},r.createElement(i.A,{handleClose:this.handleClose,handleShow:this.handleShow,show:this.state.show,thumbnail:"/All-Together-Video-Thumbnail.jpg",url:"https://player.vimeo.com/progressive_redirect/playback/1006011773/rendition/1080p/file.mp4?loc=external&signature=766e19f52d4ffc4dc70973ef57a78376b7ca625fe5e1ee24abbde6bd6602a889",videoTrackLabel:"What We Live For"}),r.createElement("img",{onClick:this.handleShow,src:"/All-Together-Video-Thumbnail.jpg",alt:"
1Video Thumbnail: GILEAD HIV What We Live For",className:"video w-100 mb-2"}),r.createElement("figcaption",{className:"font-italic pt-1 pb-3"},"Watch to see how it takes all of us in the HIV community working together to overcome the challenges that stand in the way of making progress in HIV.")),r.createElement("div",{className:"tag-row about text-center"},r.createElement("div",{className:"button secondary large mr-3 mb-3","data-jump-link":"pioneering-science"},"Pioneering Science & Innovation"),r.createElement("div",{className:"button secondary large mr-3 mb-3","data-jump-link":"improving-access"},"Expanding Access to Care"),r.createElement("div",{className:"button secondary large mr-3 mb-3","data-jump-link":"corporate-giving"},"Corporate Giving"),r.createElement("div",{className:"button secondary large mr-3 mb-3","data-jump-link":"providing-education"},"Providing Education"),r.createElement("div",{className:"button secondary large","data-jump-link":"fostering-community"},"Working Together to Help End the Hiv Epidemic"))),r.createElement(g.A,{xs:12,className:"section mb-standard"},r.createElement("h2",{"data-jump-destination":"pioneering-science",className:"title"},r.createElement("span",{className:"eyebrow"},"Pioneering Science ",r.createElement("span",{className:"d-block-inline"},"& Innovation")),r.createElement("span",{className:"d-block mt-3"},"ALL IN FOR THE ADVANCEMENT OF PREVENTION, TREATMENT, AND A CURE")),r.createElement(h.A,{className:"px-0"},r.createElement(u.A,null,r.createElement(g.A,{xs:12},r.createElement("p",null,"We have been committed to leading advancements in medicine since the beginning of the HIV epidemic. Early on, HIV treatments were complex and burdensome, sometimes requiring more than 20 pills a day.",r.createElement("sup",null,"1")," Recognizing this unmet need, we worked to develop treatments that were one or two pills a day. This approach led to the development of multiple therapies for the treatment of HIV. We have also launched medicines used as pre-exposure prophylaxis (PrEP) to help prevent HIV transmission. And together with the community, we're working to make sure that prevention means more than just preventing the acquisition of HIV with medicine."),r.createElement("p",{className:"mb-0"},"Although HIV is now considered a chronic, manageable disease, there is no cure for HIV.",r.createElement("sup",null,"2,3")," We are committed to driving forward research in pursuit of a cure to help put HIV and its impact in the past. Building on our history of curing difficult diseases, we are working to find a cure for HIV in our own labs and with more than 100 research partners. We continue to focus on increasing HIV testing and innovating across the HIV care continuum with the hopes that, when coupled with the ongoing efforts to break down barriers to care wherever they are, the age of HIV can one day come to an end."))))),r.createElement(g.A,{xs:12,className:"section mb-standard"},r.createElement("h2",{"data-jump-destination":"improving-access",className:"title"},r.createElement("span",{className:"eyebrow"},"Expanding Access to Care"),r.createElement("span",{className:"d-block mt-3"},"HELPING BREAK DOWN BARRIERS")),r.createElement("img",{className:"mx-auto pb-3 mb-1 d-none d-md-block w-85",src:s,alt:"Helping Break Down Barriers' Together image, 3 people close together, full color"}),r.createElement("img",{className:"mx-auto pb-3 mb-1 d-block d-md-none w-85",src:l,alt:"Helping Break Down Barriers' Together image, 3 people close together, full color"}),r.createElement("p",null,"People impacted by HIV have historically faced a wide range of systemic barriers that stand in the way of obtaining equitable care.",r.createElement("sup",null,"4")," Race, sexual identity, geographic location, and socioeconomic status are among many factors across which we see vast, persistent health disparities caused by stigma, racism, unequal access to healthcare, and other barriers.",r.createElement("sup",null,"5")," By working together with advocacy groups and community organizations, weâre committed to breaking down barriers to inequality by supporting HIV communities, exposing and removing the underlying social and systemic factors, creating policy reform, and supporting grassroots activism."),r.createElement("p",null,"In the United States, weâve created programs to offer information and resources to help people connect with the care they need. The Gilead Advancing Access",r.createElement("sup",null,"®")," ","program helps eligible individuals, whether they are insured or uninsured, understand their coverage and identify financial support options available to them. Through the Advancing Access Patient Assistance Program, eligible patients without insurance may be able to re
1ceive the Gilead HIV treatment and HIV prevention medications their healthcare professional has prescribed free of charge. For individuals who have commercial insurance, but need help paying for their out-of-pocket costs, the Advancing Access Co-pay Coupon Program* provides co-pay assistance to eligible patients for their prescribed Gilead HIV medications."),r.createElement("p",null,"To help make it easier for people to access the medicine they need around the world, in 2003, we launched programs to provide access to our medicines in 140 low- and middle-income countries. Since 2018, more than 12 million people have benefited from Gilead medicines in low- and middle-income countries. We also know it will take more than medicine to end the HIV epidemic and thatâs why we work with public health officials, community advocates, researchers, doctors, and patients to understand barriers and opportunities in communities impacted by HIV."),r.createElement("p",{class:"footnote"},r.createElement("span",{className:"sup"},"*"),"For commercially insured eligible patients only. Restrictions apply. See terms and conditions at"," ",r.createElement("a",{href:"https://www.GileadAdvancingAccess.com",style:{textDecoration:"underline"}},"www.GileadAdvancingAccess.com"))),r.createElement(g.A,{xs:12,className:"section corporate-giving mb-standard"},r.createElement("h2",{"data-jump-destination":"corporate-giving",className:"title text-uppercase "},r.createElement("span",{className:"eyebrow"},"Corporate Giving"),r.createElement("span",{className:"d-block mt-3"},"OFFERING SUPPORT AND RESOURCES")),r.createElement("img",{className:"d-none d-md-block mx-auto pb-3 mb-1 w-85",src:d,alt:"Offering Support and Resources' Together image, two men hugging, looking off into distance, full color"}),r.createElement("img",{className:"d-block d-md-none mx-auto pb-3 mb-1 w-85",src:p,alt:"Offering Support and Resources' Together image, two men hugging, looking off into distance, full color"}),r.createElement("p",null,"The work being done throughout the HIV community to create meaningful change inspires us to help build the community from within, amplify those everyday efforts, and address the barriers to care. As part of this commitment, through our grantee programs, we support patient advocates, healthcare professionals, and nonprofit groups around the world that work tirelessly in local communities to help improve the lives of people affected by HIV. We have been recognized as one of the top private funders of HIV-related programs.",r.createElement("sup",null,"6")," In 2022, Gilead:"),r.createElement("ul",{className:"mb-0"},r.createElement("li",null,"Distributed 948 HIV-related grants totaling just over "," ",r.createElement("span",{className:"font-heavy font-red"},"$177 million")," ","for HIV-related projects"),r.createElement("li",null,"Was recognized by Funders Concerned about AIDS (FCAA), as the"," ",r.createElement("span",{className:"font-heavy font-red"},"#2 philanthropic funder of HIV-related programs globally and #1 in the United States")),r.createElement("li",null,"Received top recognition as the"," ",r.createElement("span",{className:"font-heavy font-red"},"#1 funder")," ","of programs providing support for:",r.createElement("ul",{className:"solid"},r.createElement("li",null,"Advocacy"),r.createElement("li",null,"General operating support"),r.createElement("li",null,"Sex workers"),r.createElement("li",null,"Transgender communities"),r.createElement("li",null,"Gay, bisexual, and other men who have sex with men"))))),r.createElement(g.A,{xs:12,className:"section mb-0 mb-md-4 pb-2 pb-md-4"},r.createElement("h2",{"data-jump-destination":"providing-education",className:"title text-uppercase "},r.createElement("span",{className:"eyebrow"},"Providing Education"),r.createElement("span",{className:"d-block mt-3"},"SHARING INSIGHTS WITH THE COMMUNITY")),r.createElement("p",null,"Together we can help end the HIV epidemic for everyone, everywhere. A key to reaching that goal is HIV education. With the belief that it is important to start educational work from the ground up, we helped to create a team of Community Liaisons to work with community organizations and healthcare professionals at the local level, taking the time to understand the needs of each community and provide tailored HIV educational resources to help end the HIV epidemic."),r.createElement("p",null,"In addition, knowledge-sharing between leaders can help us support one another in our
1common goal of helping end the HIV epidemic. To this end, we have created educational programs aimed at addressing emerging trends and issues impacting the HIV epidemic to provoke thought leadership in the HIV space. The Blueprints for Success Training Institutes is a series on virtual skill-building programs for leaders in HIV to help equip them with the knowledge and tools to address new challenges around HIV care and prevention. Examples of topics covered include Cultural Humility, Institutional Stigma, and Telemedicine."),r.createElement("p",null,"Weâve also created educational sites that feature programs designed to educate and share facts about HIV to help people protect themselves and each other, including:"))),r.createElement(u.A,{className:"justify-content-between"},r.createElement(g.A,{xs:10,lg:4,className:"px-0 edu-card mx-auto mx-md-0 mb-4 mb-md-0"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.hivtestnow.com"},r.createElement("img",{className:"pb-3",src:"data:image/png;base64,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",alt:"Press Play logo, click to visit the website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1 hover-underline"},"HIV Test Now"))),r.createElement("p",{className:"mb-0"},"HIV testing is an important part of self-care. HIV Test Now is an educational resource to help people get tested and know their HIV status.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 edu-card mx-auto mx-md-0 mb-4 mb-md-0"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.helpstopthevirus.com"},r.createElement("img",{className:"pb-3",src:c,alt:"Image of Stop the Virus logo. Working together to help stop the virus. Click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1 hover-underline"},"Help Stop the Virus"))),r.createElement("p",{className:"mb-0"},"HIV education for everyone, showing how prevention, testing, and treatment work together to help stop HIV in our bodies and communities, featuring videos and other resources.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 edu-card mx-auto mx-md-0 mb-4 mb-md-0 "},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.healthysexuals.com/"},r.createElement("img",{className:"pb-3",src:m,alt:"Image of Healthysexual ® Logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1"},r.createElement("span",{className:"hover-underline"},"Healthysexual"),r.createElement("sup",null,"®")))),r.createElement("p",null,"Teaching individuals how to protect their sexual health through tips and other materials, with a focus on everyone knowing about their HIV prevention options.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 edu-card mx-auto mx-md-0"})),r.createElement(u.A,null,r.createElement(g.A,{xs:12,className:"section mb-4 pb-4 px-0"},r.createElement("h2",{"data-jump-destination":"fostering-community",className:"title text-uppercase "},"WORKING TOGETHER TO HELP END THE HIV EPIDEMIC"),r.createElement("p",null,"None of us can do this work aloneâseeing the age of HIV come to an end is a collective mission. Thatâs why we work closely with healthcare providers, researchers, academics, policymakers, advocates, activists, people living with HIV, and those affected by HIV."),r.createElement("p",null,"Working with the community toward our
1collective, common goal of ending the HIV epidemic, weâre supporting the innovative work of grassroots organizations to help improve access to care by eliminating barriers and advancing education. Below are some of our key partnerships and initiatives in HIV:"))),r.createElement(u.A,{className:"justify-content-between mb-0 mb-md-4"},r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0 mb-4"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.gilead.com/purpose/health-equity"},r.createElement("img",{className:"pb-3",src:"/Advancing-health-equity-logo.jpg",alt:"Image of Advancing Health Equity logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1 hover-underline"},"Advancing Health Equity at Gilead"))),r.createElement("p",null,"We leverage our decades of clinical expertise, scientific innovation, and deep relationships with community partners to continue advancing equity for people with the greatest unmet needs. Our health equity efforts enable us to reach more people with our innovative therapies, especially those in marginalized and disinvested communities where individuals are disproportionately impacted by the diseases we seek to prevent, treat and cure. We have identified three global health equity priorities that will help us achieve our mission of creating a healthier world for all people: helping to enable access to life-changing medicines, delivering innovation to reduce inequities, and igniting social impact to advance human rights for communities.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0 mb-4"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://aidsvu.org/"},r.createElement("img",{className:"pb-3",src:"/aidsvu-logo.png",alt:"Image of AIDSVu.org Logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1 hover-underline"},"AIDSVu.org"))),r.createElement("p",null,"Launched in partnership between Gilead and Emory Universityâs Rollins School of Public Health and the Center for AIDS Research at Emory University (CFAR), AIDSVu.org is an interactive mapping tool that helps users visualize HIV data at the national, regional, and local levels, and provides location services for HIV testing, prevention, and care.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.gileadcompass.com/"},r.createElement("img",{className:"pb-3",src:"/compass-initiative-logo.png",alt:"Image of COMPASS Initiative® Logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1"},r.createElement("span",{className:"hover-underline"},"COMPASS Initiative"),r.createElement("sup",null,"®")))),r.createElement("p",null,"(COMmitment to Partnership in Addressing HIV/AIDS in Southern States): Gilead's over $100M, 10-year commitment to help address the HIV epidemic in the US South.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0 mb-4"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.gilead.com/purpose/partnerships-and-community/hiv-age-positively"},r.createElement("img",{className:"pb-3",src:"/hiv-age-positively-logo.png",alt:"Image of HIV Age Positively®, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1"},r.createElement("span",{className:"hover-underline"},"HIV Age Positively"),r.createElement("sup",null,"®")))),r.createElement("p",null,"Aims to support programs focused on improving the quality of life and health of those aging with HIV, and making an impact on HIV policy.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0 mb-4"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://radianhiv.org/"},r.createElement("img",{className:"pb-3",src:"/radian-logo.png",alt:"Image of Radian® Logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1"},r.createElement("span",{className:"hover-underline"}
1,"RADIAN"),r.createElement("sup",null,"®")))),r.createElement("p",null,"A partnership between Gilead Sciences and the Elton John AIDS Foundation to address new HIV infections and deaths from HIV-related illnesses in Eastern Europe and Central Asia.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0 mb-4"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.gilead.com/purpose/partnerships-and-community/transcend"},r.createElement("img",{className:"pb-3",src:"/transcend-logo.png",alt:"Image of TRANScend® Logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1"},r.createElement("span",{className:"hover-underline"},"TRANScend"),r.createElement("sup",null,"®")))),r.createElement("p",null,"Supports trans-led organizations working to reduce the impact of HIV within non-binary and transgender communities.")),r.createElement(g.A,{xs:10,lg:4,className:"px-0 partner-card mx-auto mx-md-0"},r.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/zeroing-in-ending-the-hiv-epidemic"},r.createElement("img",{className:"pb-3",src:"/WebZeroingIng.jpg",alt:"Zeroing In: Ending the HIV Epidemic® logo, click to visit their website"}),r.createElement("p",{className:"mb-0"},r.createElement("span",{className:"font-heavy font-red d-block pb-1"},r.createElement("span",{className:"hover-underline"},"Zeroing In: Ending the HIV Epidemic"),r.createElement("sup",null,"®")))),r.createElement("p",null,"Supports organizations and partners who are working to increase the overall health and wellness of communities most impacted by HIV and the COVID-19 pandemic."))),r.createElement(u.A,null,r.createElement(g.A,{xs:12,className:"section mb-3 px-0"},r.createElement("h3",{className:"title text-uppercase "},"MOVING AHEAD, TOGETHER"),r.createElement("p",null,"To keep forward momentum on all of these causes, weâve created this website as an educational resource for emerging leaders and advocates in the HIV community who are engaged in our shared work to help end the HIV epidemic for everyone, everywhere."),r.createElement("a",{href:"/",className:"button medium secondary"},"Explore more"))))))),r.createElement(h.A,{className:"px-0"},r.createElement(u.A,null,r.createElement(g.A,{xs:12,className:"px-0"},r.createElement(E.A,null)))),r.createElement(b.A,{page:this.props.page}))},t}(r.Component);let y=function(e){function t(){return e.apply(this,arguments)||this}return(0,n.A)(t,e),t.prototype.render=function(){return r.createElement(r.Fragment,null,r.createElement(o.A,{section:"about",page:"about"},r.createElement(w,{section:"about",page:"about"})))},t}(r.Component);var I=y}}]); 2//# sourceMappingURL=component---src-pages-about-us-js-7fe3811ca1c7b30ffa19.js.map
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.